STOCK TITAN
  1. Home
  2. Sec-filings
  3. WINT
  4. [EFFECT] Windtree Therapeutics, Inc. SEC Filing

[EFFECT] Windtree Therapeutics, Inc. SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
EFFECT
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: July 11, 2025 12:00 P.M.
Form: S-1
CIK: 0000946486
Company Name: WINDTREE THERAPEUTICS INC /DE/
File Number: 333-287358

Source: View Original Filing on SEC EDGAR

Stock WINT logo
Windtree Therapeutics Inc

OTC:WINT

WINT Rankings

#6199 Ranked by Market Cap
N/A Ranked by Dividends

WINT Latest News

Dec 23, 2025
Windtree Therapeutics Announces the Sale of its Cardiovascular Biotech Pipeline Drug Candidates
Dec 3, 2025
Windtree Therapeutics Announces It Has Signed a Letter of Intent to Acquire CommLoan, Inc. a Revenue Generating Company in the Rapidly Growing Fintech Space
Nov 17, 2025
Windtree Therapeutics Announces It May Receive License Agreement Payments from Its Licensee for Renewed Acute Pulmonary Development by the Licensee
Nov 14, 2025
Windtree Therapeutics Announces More Strengthening of Its Istaroxime and Next Generation SERCA2a activator Patent Estate
Nov 13, 2025
Windtree Therapeutics Announces It Will Receive $7.5 Million In Cash and Securities from the Recently Executed Termination Agreement with an Environmental Services Company

WINT Latest SEC Filings

Jan 7, 2026
[8-K] WINDTREE THERAPEUTICS INC /DE/ Reports Material Event
Dec 2, 2025
[8-K] WINDTREE THERAPEUTICS INC /DE/ Reports Material Event
Nov 19, 2025
[10-Q] WINDTREE THERAPEUTICS INC /DE/ Quarterly Earnings Report
Nov 14, 2025
[NT 10-Q] WINDTREE THERAPEUTICS INC /DE/ SEC Filing
Oct 24, 2025
[S-1] WINDTREE THERAPEUTICS INC /DE/ Files IPO Registration Statement

WINT Stock Data

13.83M
33.71M
0%
0.08%
6.25%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States
WARRINGTON